Board Meeting27 May 2026, 05:01 pm
Godavari Drugs Approves Financial Results for FY26
AI Summary
Godavari Drugs Ltd's Board Meeting on May 27, 2026, approved the audited financial results for the quarter and financial year ended March 31, 2026. The board also approved the appointment of M/s. S.K. Lahoti Associates as Internal Auditors and M/S. Bharathula & Associates as Cost Auditors for FY 2026-27, subject to shareholder ratification. The 38th Annual General Meeting is scheduled for September 25, 2026, via video conferencing.
Key Highlights
- Audited financial results for FY26 approved with unmodified auditor's opinion.
- M/s. S.K. Lahoti Associates appointed as Internal Auditors for FY27.
- M/S. Bharathula & Associates appointed as Cost Auditors for FY27, subject to shareholder approval.
- 38th AGM scheduled for September 25, 2026, via video conferencing.
Price Impact
More from GODAVARI